{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T23:47:15Z","timestamp":1776210435484,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013362","name":"Swiss Cancer Research Foundation","doi-asserted-by":"publisher","award":["KFS-5389-08-2021-R"],"award-info":[{"award-number":["KFS-5389-08-2021-R"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013362","name":"Swiss Cancer Research Foundation","doi-asserted-by":"publisher","award":["-5389-08-2021-R"],"award-info":[{"award-number":["-5389-08-2021-R"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014069","name":"Funda\u00e7\u00e3o Champalimaud","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["LISBOA-01-0145-FEDER-022170"],"award-info":[{"award-number":["LISBOA-01-0145-FEDER-022170"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["PTDC\/BTM-SAL\/3796\/2021"],"award-info":[{"award-number":["PTDC\/BTM-SAL\/3796\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005032","name":"Bial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005032","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.xcrm.2025.102530","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T15:59:07Z","timestamp":1767110347000},"page":"102530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["zAvatar-test\u2014A functional precision model to personalize ovarian cancer treatments: Results from a co-clinical study"],"prefix":"10.1016","volume":"7","author":[{"given":"Marta F.","family":"Estrada","sequence":"first","affiliation":[]},{"given":"Filipa","family":"Amorim","sequence":"additional","affiliation":[]},{"given":"Filipa","family":"Ferreira da Silva","sequence":"additional","affiliation":[]},{"given":"C\u00e1tia","family":"Rebelo de Almeida","sequence":"additional","affiliation":[]},{"given":"M\u00e1rcia","family":"Fontes","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"Coelho","sequence":"additional","affiliation":[]},{"given":"S\u00f3nia","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Canas-Marques","sequence":"additional","affiliation":[]},{"given":"Mireia","family":"Castillo-Martin","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Casanova","sequence":"additional","affiliation":[]},{"given":"Maria de Lurdes","family":"Batarda","sequence":"additional","affiliation":[]},{"given":"Elisa","family":"Yaniz-Galende","sequence":"additional","affiliation":[]},{"given":"Audrey","family":"LeFormal","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Marreiros","sequence":"additional","affiliation":[]},{"given":"Francis","family":"Jacob","sequence":"additional","affiliation":[]},{"given":"Viola","family":"Heinzelmann-Schwarz","sequence":"additional","affiliation":[]},{"given":"Alexandra","family":"Leary","sequence":"additional","affiliation":[]},{"given":"Henrique","family":"Nabais","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5550-2428","authenticated-orcid":false,"given":"Rita","family":"Fior","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102530_bib1","doi-asserted-by":"crossref","first-page":"22832","DOI":"10.18632\/oncotarget.25126","article-title":"Role of tumor microenvironment in ovarian cancer pathobiology","volume":"9","author":"Ghoneum","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2025.102530_bib2","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","article-title":"An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity","volume":"25","author":"Kopper","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102530_bib3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.21037\/tcr.2016.08.40","article-title":"TP53 mutations in epithelial ovarian cancer","volume":"5","author":"Zhang","year":"2016","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102530_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","article-title":"The untapped potential of ascites in ovarian cancer research and treatment","volume":"123","author":"Ford","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.xcrm.2025.102530_bib5","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s12094-020-02545-x","article-title":"SEOM clinical guideline in ovarian cancer (2020)","volume":"23","author":"Redondo","year":"2021","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.xcrm.2025.102530_bib6","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1002\/cncr.32500","article-title":"Treatment of recurrent epithelial ovarian cancer","volume":"125","author":"Pignata","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.xcrm.2025.102530_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107762","article-title":"Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses","volume":"31","author":"de Witte","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2025.102530_bib8","first-page":"413","article-title":"Natural and Chemotherapy-Induced Clonal Evolution of Tumors","volume":"82","author":"Ibragimova","year":"2017","journal-title":"Biochemistry."},{"key":"10.1016\/j.xcrm.2025.102530_bib9","article-title":"Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts","volume":"34","author":"Fior","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102530_bib10","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1038\/s41467-024-49051-0","article-title":"Zebrafish Avatar-test forecasts clinical response to chemotherapy in patients with colorectal cancer","volume":"15","author":"Costa","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102530_bib11","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/s41467-021-21421-y","article-title":"Innate immune evasion revealed in a colorectal zebrafish xenograft model","volume":"12","author":"P\u00f3voa","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102530_bib12","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.050693","article-title":"Macrophages directly kill bladder cancer cells through TNF signaling as an early response to BCG therapy","volume":"17","author":"Mart\u00ednez-L\u00f3pez","year":"2024","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.xcrm.2025.102530_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12935-019-1022-8","article-title":"PAX8 expression in high-grade serous ovarian cancer positively regulates attachment to ECM via Integrin \u03b23","volume":"19","author":"Soriano","year":"2019","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.xcrm.2025.102530_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3892\/etm.2020.9594","article-title":"Inflammatory signals induce MUC16 expression in ovarian cancer cells via NF-\u03baB activation","volume":"21","author":"Liu","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.xcrm.2025.102530_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.yexcr.2005.11.004","article-title":"Multiple roles of alpha-smooth muscle actin in mechanotransduction","volume":"312","author":"Wang","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.xcrm.2025.102530_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/labinvest.2016.116","article-title":"CD68\/macrosialin: not just a histochemical marker","volume":"97","author":"Chistiakov","year":"2017","journal-title":"Lab. Invest."},{"key":"10.1016\/j.xcrm.2025.102530_bib17","first-page":"114","article-title":"Characterization of normal human CD3+ CD5- and gamma delta T cell receptor positive T lymphocytes","volume":"80","author":"Spour","year":"1990","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.xcrm.2025.102530_bib18","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41571-023-00819-1","article-title":"Heterogeneity and treatment landscape of ovarian carcinoma","volume":"20","author":"Veneziani","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102530_bib19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nm.2328","article-title":"Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression","volume":"17","author":"Bissell","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102530_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s42003-020-1015-0","article-title":"Zebrafish xenografts as a fast screening platform for bevacizumab cancer therapy","volume":"3","author":"Rebelo de Almeida","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.xcrm.2025.102530_bib21","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1136\/ijgc-2021-002978","article-title":"Ascites volume at the time of primary debulking and overall survival of patients with advanced epithelial ovarian cancer","volume":"31","author":"Nasioudis","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.xcrm.2025.102530_bib22","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/jog.14682","article-title":"Relationship between ascites volume and clinical outcomes in epithelial ovarian cancer","volume":"47","author":"Quan","year":"2021","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.xcrm.2025.102530_bib23","doi-asserted-by":"crossref","first-page":"15154","DOI":"10.1038\/s41598-021-93718-3","article-title":"A large-scale multi-institutional study evaluating prognostic aspects of positive ascites cytology and effects of therapeutic interventions in epithelial ovarian cancer","volume":"11","author":"Yoshihara","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2025.102530_bib24","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1053\/j.seminoncol.2006.03.012","article-title":"Management of platinum-sensitive recurrent ovarian cancer","volume":"33","author":"Pfisterer","year":"2006","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102530_bib25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ygyno.2004.10.026","article-title":"Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease","volume":"96","author":"Williams","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.xcrm.2025.102530_bib26","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3892\/ijo.2017.3914","article-title":"Apoptosis is augmented in high-grade serous ovarian cancer by the combined inhibition of Bcl-2\/Bcl-xL and PARP","volume":"50","author":"Yokoyama","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.xcrm.2025.102530_bib27","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/annonc\/mdx416","article-title":"Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors","volume":"28","author":"Izumchenko","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2025.102530_bib28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/cells9020293","article-title":"Zebrafish Avatars towards Personalized Medicine-A Comparative Review between Avatar Models","volume":"9","author":"Costa","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2025.102530_bib29","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.ccell.2022.09.017","article-title":"A path to translation: How 3D patient tumor avatars enable next generation precision oncology","volume":"40","author":"Bose","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102530_bib30","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.medj.2021.08.005","article-title":"Promises and Challenges of Organoid-Guided Precision Medicine","volume":"2","author":"Bose","year":"2021","journal-title":"Med"},{"key":"10.1016\/j.xcrm.2025.102530_bib31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13046-021-01917-7","article-title":"Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine","volume":"40","author":"Nero","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102530_bib32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41698-025-00882-0","article-title":"Zebrafish Avatar testing preclinical study predicts chemotherapy response in breast cancer","volume":"9","author":"Mendes","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.xcrm.2025.102530_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101162","article-title":"Zebrafish patient-derived xenograft system for predicting carboplatin resistance and metastasis of ovarian cancer","volume":"78","author":"Song","year":"2025","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.xcrm.2025.102530_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41698-024-00550-9","article-title":"Zebrafish tumour xenograft models: a prognostic approach to epithelial ovarian cancer","volume":"8","author":"Lindahl","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.xcrm.2025.102530_bib35","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.3390\/cancers13174318","article-title":"Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response","volume":"13","author":"Rickard","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2025.102530_bib36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/dbio.2002.0711","article-title":"In vivo imaging of embryonic vascular development using transgenic zebrafish","volume":"248","author":"Lawson","year":"2002","journal-title":"Dev. Biol."},{"key":"10.1016\/j.xcrm.2025.102530_bib37","doi-asserted-by":"crossref","first-page":"e36131","DOI":"10.7554\/eLife.36131","article-title":"Adult zebrafish Langerhans cells arise from hematopoietic stem\/progenitor cells","volume":"7","author":"He","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.xcrm.2025.102530_bib38","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1039\/C4NR07641A","article-title":"Biodegradable polymeric micelle-encapsulated doxorubicin suppresses tumor metastasis by killing circulating tumor cells","volume":"7","author":"Deng","year":"2015","journal-title":"Nanoscale"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125006032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125006032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:51:25Z","timestamp":1776207085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125006032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2666379125006032"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102530","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"zAvatar-test\u2014A functional precision model to personalize ovarian cancer treatments: Results from a co-clinical study","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102530"}}